Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to determine the safety and effectiveness of second trimester medical abortion when provided by nurse midwives compared with physicians. The study sample will be obtained from Michu Clinic, affiliated with St Paul's hospital, in Addis Ababa.


Clinical Trial Description

About 10% of all abortions globally take place at or after 13 weeks gestation. Women seeking second-trimester abortion services are often the most vulnerable and socially disadvantaged population.Studies show the rate of second-trimester abortion procedures remains stable over time, even in high-access locations, confirming the ongoing need for accessibility to services in rural locations with limited access to care. In Ethiopia, second-trimester abortion services are widely available in Addis Ababa, making up a high proportion of the total number of abortions occurring each year in the country; however, access to accurate and reliable data is limited. The World Health Organization recommends that abortion can be provided at the lowest level of the healthcare system (WHO abortion guidelines). Training mid-level providers, such as midwives, nurses and other non-physician providers, to conduct second trimester aspiration abortions is proposed as a way to increase women's access to safe abortion procedures and has been highlighted by the WHO as an area in which rigorous research is needed (WHO task-sharing guidelines). The investigators seek to conduct a comparative study of patients undergoing second trimester medical abortion provided by either physicians or nurse midwives. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04181541
Study type Interventional
Source Ipas
Contact
Status Completed
Phase N/A
Start date February 17, 2020
Completion date March 3, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02745093 - Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Phase 4
Completed NCT02570204 - Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests N/A
Completed NCT01487213 - Routine Follow-up Versus Self-assessment in Medical Abortion N/A
Terminated NCT05119439 - Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks Phase 4
Terminated NCT04941443 - Methadone and Medication Abortion Phase 4
Completed NCT02985229 - Acceptability and Feasibility of Medical Abortion in Singapore Phase 3
Completed NCT01920022 - Quickstart of Nexplanon® at Medical Abortion Phase 4
Completed NCT00472394 - Determining Women's Preferences for Medical Abortion Using Willingness to Pay N/A
Completed NCT03604341 - Cannabinoids for Pain Control During Medical Abortion Phase 4
Completed NCT00907725 - Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion? N/A
Completed NCT00120224 - De-Medicalizing Mifepristone Medical Abortion N/A
Completed NCT03148587 - Medical Abortion Self-Confirmation (MASC) N/A
Completed NCT00621543 - Insertion of an Intrauterine Device (IUD) After Medical Abortion N/A
Completed NCT02343913 - Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan N/A
Completed NCT01856777 - Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy N/A
Recruiting NCT00920465 - Treatment Regimens for Mifegyne and Cytotec Phase 3
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Completed NCT00997347 - The Extended Gestational Age Medical Abortion Study Phase 4
Completed NCT03014193 - Simplifying First Trimester Medical Abortion Follow-up N/A
Recruiting NCT04905251 - Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion